Dental supply maker Patterson Companies Inc (NASDAQ:PDCO) announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value.
What Happened: The company disclosed the sale process as part of its second-quarter financial report.
Earnings were mixed, “given the challenging end market environment,” said Patterson CEO Don Zurbay.
Patterson posted second-quarter 2025 net sales of $1.67 billion. That’s up 1.3% year-over-year. Wall Street expected a net sales of $1.65 billion. Internal sales increased just 0.6%.
Here’s a breakdown of the dental business:
As for Patterson’s animal health segment:
The company reported adjusted EPS of 47 cents. That’s down from 50 cents a year ago. It missed the consensus of 49 cents.
GAAP and adjusted earnings were also negatively impacted by the Change Healthcare cyber attack.
Patterson “took dedicated cost management actions” and “made targeted investments in complementary businesses,” according to Zurbay.
Outlook: Patterson expects fiscal year 2025 adjusted EPS Of $2.25-$2.35 compared to the consensus of $2.32 and prior guidance of $2.33-$2.43.
Price Action: Patterson stock is up 6.54% at $23.31 during the premarket session at last check Thursday.
Read Next:
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。